These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22912588)

  • 21. Phospholipid flippase ATP8A2 is required for normal visual and auditory function and photoreceptor and spiral ganglion cell survival.
    Coleman JA; Zhu X; Djajadi HR; Molday LL; Smith RS; Libby RT; John SW; Molday RS
    J Cell Sci; 2014 Mar; 127(Pt 5):1138-49. PubMed ID: 24413176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATP8A2-related disorders as recessive cerebellar ataxia.
    Guissart C; Harrison AN; Benkirane M; Oncel I; Arslan EA; Chassevent AK; Baraῆano K; Larrieu L; Iascone M; Tenconi R; Claustres M; Eroglu-Ertugrul N; Calvas P; Topaloglu H; Molday RS; Koenig M
    J Neurol; 2020 Jan; 267(1):203-213. PubMed ID: 31612321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.
    Wang AL; Yuan M; Neufeld AH
    J Neurosci Res; 2006 Dec; 84(8):1799-807. PubMed ID: 17022038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of axonal spheroid formation in central nervous system Wallerian degeneration.
    Beirowski B; Nógrádi A; Babetto E; Garcia-Alias G; Coleman MP
    J Neuropathol Exp Neurol; 2010 May; 69(5):455-72. PubMed ID: 20418780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Atypical SCF-like Ubiquitin Ligase Complex Promotes Wallerian Degeneration through Regulation of Axonal Nmnat2.
    Yamagishi Y; Tessier-Lavigne M
    Cell Rep; 2016 Oct; 17(3):774-782. PubMed ID: 27732853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of the ATP8A2 gene in a patient with a t(10;13) de novo balanced translocation and a severe neurological phenotype.
    Cacciagli P; Haddad MR; Mignon-Ravix C; El-Waly B; Moncla A; Missirian C; Chabrol B; Villard L
    Eur J Hum Genet; 2010 Dec; 18(12):1360-3. PubMed ID: 20683487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.
    Giasson BI; Duda JE; Quinn SM; Zhang B; Trojanowski JQ; Lee VM
    Neuron; 2002 May; 34(4):521-33. PubMed ID: 12062037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sprouting of axonal collaterals after spinal cord injury is prevented by delayed axonal degeneration.
    Collyer E; Catenaccio A; Lemaitre D; Diaz P; Valenzuela V; Bronfman F; Court FA
    Exp Neurol; 2014 Nov; 261():451-61. PubMed ID: 25079366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system.
    Coleman MP; Ribchester RR
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):227-38. PubMed ID: 15180483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-axonal calcium changes after axotomy in wild-type and slow Wallerian degeneration axons.
    Adalbert R; Morreale G; Paizs M; Conforti L; Walker SA; Roderick HL; Bootman MD; Siklós L; Coleman MP
    Neuroscience; 2012 Dec; 225():44-54. PubMed ID: 22960623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axon degeneration: Mechanisms and implications of a distinct program from cell death.
    Yan T; Feng Y; Zhai Q
    Neurochem Int; 2010 Mar; 56(4):529-34. PubMed ID: 20117162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P4-ATPase ATP8A2 acts in synergy with CDC50A to enhance neurite outgrowth.
    Xu Q; Yang GY; Liu N; Xu P; Chen YL; Zhou Z; Luo ZG; Ding X
    FEBS Lett; 2012 Jun; 586(13):1803-12. PubMed ID: 22641037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophy.
    McMillan HJ; Telegrafi A; Singleton A; Cho MT; Lelli D; Lynn FC; Griffin J; Asamoah A; Rinne T; Erasmus CE; Koolen DA; Haaxma CA; Keren B; Doummar D; Mignot C; Thompson I; Velsher L; Dehghani M; Vahidi Mehrjardi MY; Maroofian R; Tchan M; Simons C; Christodoulou J; Martín-Hernández E; Guillen Sacoto MJ; Henderson LB; McLaughlin H; Molday LL; Molday RS; Yoon G
    Orphanet J Rare Dis; 2018 May; 13(1):86. PubMed ID: 30012219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo.
    Di Stefano M; Loreto A; Orsomando G; Mori V; Zamporlini F; Hulse RP; Webster J; Donaldson LF; Gering M; Raffaelli N; Coleman MP; Gilley J; Conforti L
    Curr Biol; 2017 Mar; 27(6):784-794. PubMed ID: 28262487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration.
    Yahata N; Yuasa S; Araki T
    J Neurosci; 2009 May; 29(19):6276-84. PubMed ID: 19439605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.
    Spittaels K; Van den Haute C; Van Dorpe J; Bruynseels K; Vandezande K; Laenen I; Geerts H; Mercken M; Sciot R; Van Lommel A; Loos R; Van Leuven F
    Am J Pathol; 1999 Dec; 155(6):2153-65. PubMed ID: 10595944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal Degeneration.
    Krauss R; Bosanac T; Devraj R; Engber T; Hughes RO
    Trends Pharmacol Sci; 2020 Apr; 41(4):281-293. PubMed ID: 32107050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axonal and neuromuscular synaptic phenotypes in Wld(S), SOD1(G93A) and ostes mutant mice identified by fiber-optic confocal microendoscopy.
    Wong F; Fan L; Wells S; Hartley R; Mackenzie FE; Oyebode O; Brown R; Thomson D; Coleman MP; Blanco G; Ribchester RR
    Mol Cell Neurosci; 2009 Dec; 42(4):296-307. PubMed ID: 19683573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prion disease development in slow Wallerian degeneration (Wld(S)) mice.
    Gültner S; Laue M; Riemer C; Heise I; Baier M
    Neurosci Lett; 2009 Jun; 456(2):93-8. PubMed ID: 19429141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.